Real-world Effectiveness and Predictors of Response to Autologous Haematopoietic Stem Cell Transplantation in MS: The UK Experience in 271 Patients Treated During 2000–2023 (S3.009)
To report on the effectiveness and predictors of response to autologous haematopoietic stem cell transplantation (AHSCT) for the treatment of multiple sclerosis (MS) in the United Kingdom (UK).
Authors
- Basil Sharrack (ORCID: https://orcid.org/0000-0003-2406-6365)
- Varun Mehra (ORCID: https://orcid.org/0000-0001-6572-0971)
- Ruth Paul
- Ram Malladi (ORCID: https://orcid.org/0000-0002-0242-630X)
- Paolo Antonio Muraro (ORCID: https://orcid.org/0000-0002-3822-1218)
- Richard Nicholas (ORCID: https://orcid.org/0000-0003-0414-1225)
- John A. Snowden (ORCID: https://orcid.org/0000-0001-6819-3476)
- Victoria Potter
- Gavin Brittain (ORCID: https://orcid.org/0000-0002-9903-7203)
- Eleonora De Matteis (ORCID: https://orcid.org/0000-0003-3468-3412)
- Rachel Pearce (ORCID: https://orcid.org/0000-0001-8343-2121)
- Maria Pia Sormani (ORCID: https://orcid.org/0000-0001-6892-104X)
- Eli Silber (ORCID: https://orcid.org/0000-0002-3972-0780)
- Julia Lee (ORCID: https://orcid.org/0000-0002-4509-6240)
- Alessio Signori
- Majid Kazmi
- Ian Gabriel
Institutions
- The King's College (US)
- King's College - North Carolina (US)
- King's College London (GB)
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Imperial College London (GB)
- University of Genoa (IT)
- University of Sheffield (GB)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212267
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00